Literature DB >> 31237944

Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Saurav Brahmachari1,2,3, Saebom Lee1,2, Sangjune Kim1,2, Changqing Yuan1,2,3, Senthilkumar S Karuppagounder1,2,3, Preston Ge1,2,3, Rosa Shi1,2,3, Esther J Kim1,2,3, Alex Liu1,2,3, Donghoon Kim1,2,4, Stephan Quintin1,2, Haisong Jiang1,2,3, Manoj Kumar1,2,3, Seung Pil Yun1,2,3, Tae-In Kam1,2,3, Xiaobo Mao1,2,3, Yunjong Lee1,2,3, Deborah A Swing5, Lino Tessarollo5, Han Seok Ko1,2,4, Valina L Dawson1,2,3,6,7, Ted M Dawson1,2,3,7,8.   

Abstract

α-Synuclein misfolding and aggregation plays a major role in the pathogenesis of Parkinson's disease. Although loss of function mutations in the ubiquitin ligase, parkin, cause autosomal recessive Parkinson's disease, there is evidence that parkin is inactivated in sporadic Parkinson's disease. Whether parkin inactivation is a driver of neurodegeneration in sporadic Parkinson's disease or a mere spectator is unknown. Here we show that parkin in inactivated through c-Abelson kinase phosphorylation of parkin in three α-synuclein-induced models of neurodegeneration. This results in the accumulation of parkin interacting substrate protein (zinc finger protein 746) and aminoacyl tRNA synthetase complex interacting multifunctional protein 2 with increased parkin interacting substrate protein levels playing a critical role in α-synuclein-induced neurodegeneration, since knockout of parkin interacting substrate protein attenuates the degenerative process. Thus, accumulation of parkin interacting substrate protein links parkin inactivation and α-synuclein in a common pathogenic neurodegenerative pathway relevant to both sporadic and familial forms Parkinson's disease. Thus, suppression of parkin interacting substrate protein could be a potential therapeutic strategy to halt the progression of Parkinson's disease and related α-synucleinopathies.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  PARIS; Parkinson’s disease; parkin; zinc finger protein 746; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31237944      PMCID: PMC6658849          DOI: 10.1093/brain/awz172

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  83 in total

Review 1.  Alpha-synuclein and neurodegenerative diseases.

Authors:  M Goedert
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.

Authors:  Y Imai; M Soda; R Takahashi
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 3.  The role of alpha-synuclein in Parkinson's disease: insights from animal models.

Authors:  Eleonora Maries; Biplob Dass; Timothy J Collier; Jeffrey H Kordower; Kathy Steece-Collier
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

4.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.

Authors:  Y Zhang; J Gao; K K Chung; H Huang; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

5.  c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.

Authors:  B B Brasher; R A Van Etten
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

Review 6.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

7.  The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.

Authors:  Olga Corti; Cornelia Hampe; Hana Koutnikova; Frédéric Darios; Sandrine Jacquier; Annick Prigent; Jean-Charles Robinson; Laurent Pradier; Merle Ruberg; Marc Mirande; Etienne Hirsch; Thomas Rooney; Alain Fournier; Alexis Brice
Journal:  Hum Mol Genet       Date:  2003-06-15       Impact factor: 6.150

8.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

9.  Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation.

Authors:  Min Jung Kim; Bum-Joon Park; Young-Sun Kang; Hyoung June Kim; Jae-Hyun Park; Jung Woo Kang; Sang Won Lee; Jung Min Han; Han-Woong Lee; Sunghoon Kim
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

10.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Authors:  Michael K Lee; Wanda Stirling; Yanqun Xu; Xueying Xu; Dike Qui; Allen S Mandir; Ted M Dawson; Neal G Copeland; Nancy A Jenkins; Don L Price
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  15 in total

1.  Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.

Authors:  Nikhil Panicker; Tae-In Kam; Hu Wang; Stewart Neifert; Shih-Ching Chou; Manoj Kumar; Saurav Brahmachari; Aanishaa Jhaldiyal; Jared T Hinkle; Fatih Akkentli; Xiaobo Mao; Enquan Xu; Senthilkumar S Karuppagounder; Eric T Hsu; Sung-Ung Kang; Olga Pletnikova; Juan Troncoso; Valina L Dawson; Ted M Dawson
Journal:  Neuron       Date:  2022-06-01       Impact factor: 18.688

2.  Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion.

Authors:  Sangwoo Ham; Seung Pil Yun; Hyojung Kim; Donghoon Kim; Bo Am Seo; Heejeong Kim; Jeong-Yong Shin; Mohamad Aasif Dar; Gum Hwa Lee; Yun Il Lee; Doyeun Kim; Sunghoon Kim; Hee-Seok Kweon; Joo-Ho Shin; Han Seok Ko; Yunjong Lee
Journal:  Sci Transl Med       Date:  2020-11-11       Impact factor: 17.956

3.  Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.

Authors:  Hyojung Kim; Jeong-Yong Shin; Areum Jo; Ji Hun Kim; Sangwook Park; Jeong-Yun Choi; Ho Chul Kang; Valina L Dawson; Ted M Dawson; Joo-Ho Shin; Yunjong Lee
Journal:  Brain       Date:  2021-12-31       Impact factor: 15.255

Review 4.  PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease.

Authors:  Preston Ge; Valina L Dawson; Ted M Dawson
Journal:  Mol Neurodegener       Date:  2020-03-13       Impact factor: 14.195

Review 5.  PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.

Authors:  Peter M J Quinn; Paula I Moreira; António Francisco Ambrósio; C Henrique Alves
Journal:  Acta Neuropathol Commun       Date:  2020-11-09       Impact factor: 7.801

Review 6.  The cell biology of Parkinson's disease.

Authors:  Nikhil Panicker; Preston Ge; Valina L Dawson; Ted M Dawson
Journal:  J Cell Biol       Date:  2021-04-05       Impact factor: 10.539

7.  Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.

Authors:  Shi-Xun Ma; Bo Am Seo; Donghoon Kim; Yulan Xiong; Seung-Hwan Kwon; Saurav Brahmachari; Sangjune Kim; Tae-In Kam; Raja Sekhar Nirujogi; Sang Ho Kwon; Valina L Dawson; Ted M Dawson; Akhilesh Pandey; Chan Hyun Na; Han Seok Ko
Journal:  J Proteome Res       Date:  2021-06-01       Impact factor: 4.466

Review 8.  Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?

Authors:  Vignayanandam Ravindernath Muddapu; S Akila Parvathy Dharshini; V Srinivasa Chakravarthy; M Michael Gromiha
Journal:  Front Neurosci       Date:  2020-03-31       Impact factor: 4.677

9.  Effect of Parkin on methamphetamine-induced α-synuclein degradation dysfunction in vitro and in vivo.

Authors:  Yunle Meng; Honghua Qiao; Jiuyang Ding; Yitong He; Haoling Fan; Chen Li; Pingming Qiu
Journal:  Brain Behav       Date:  2020-02-21       Impact factor: 2.708

10.  Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons.

Authors:  Manoj Kumar; Jesús Acevedo-Cintrón; Aanishaa Jhaldiyal; Hu Wang; Shaida A Andrabi; Stephen Eacker; Senthilkumar S Karuppagounder; Saurav Brahmachari; Rong Chen; Hyesoo Kim; Han Seok Ko; Valina L Dawson; Ted M Dawson
Journal:  Stem Cell Reports       Date:  2020-08-13       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.